News

Jack Link’s introduces new limited-edition, globally-inspired snacks

BY Jason Owen

MINONG, Wis. — Jack Link’s announced this month two new limited-edition snacks that draw inspiration from global cuisines in Southeast Asia and Latin America.

Jack Link’s new Sriracha beef and Burrito beef jerky are the latest additions to the Jack Link’s line of meat snacks.

“As the fastest growing meat snack brand, Jack Link’s is continually creating exciting new meat snack flavors to meet the demands of consumers’ ever-evolving palates,” said Kevin Papacek, director of marketing, Jack Link’s. “Both of Jack Link’s new globally-inspired flavors — Sriracha beef jerky and Burrito beef jerky — invite today’s snackers to unleash their adventurous spirits with the bold and spicy tastes of their favorite foods."

Jack Link’s Sriracha beef jerky is made with hot chili peppers and garlic, providing the spice and heat of Sriracha hot sauce.

The new Burrito beef jerky is inspired by a Latin American concoction of spicy chili peppers, onions and garlic.

Requiring no refrigeration, both new offerings are packaged for snacking on the road, at home or anywhere in between. Each 3.25-oz. bag of Jack Link’s Sriracha beef jerky and Burrito beef jerky includes 15 g of protein, is 97% fat free and is low in calories and carbs, making the products a smart alternative to carb-laden, high-fat snacks.

Jack Link’s Sriracha and Burrito beef jerky are now available at retail locations across the country for a suggested retail price of $6.99.


Like this story? Find us on Facebook for more insight, analysis and the latest in drug store news. Join the conversation.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
News

FDA approves J&J’s Stelara for psoriatic arthritis

BY Alaric DeArment

HORSHAM, Pa. — The Food and Drug Administration has approved a drug made by Johnson & Johnson for psoriatic arthritis, the company said Monday.

Janssen Biotech, a subsidiary of J&J, announced the approval of Stelara (ustekinumab) alone or combined with the common generic drug methotrexate for treating active psoriatic arthritis in adults. According to the National Psoriasis Foundation, the autoimmune disease is estimated to affect more than 2 million people in the United States and is characterized by joint inflammation and psoriasis skin lesions.

"It is critical for dermatologists and rheumatologists to be able to offer new and novel treatment options to our adult patients living with psoriatic arthritis, a disease where additional biologic options are very much needed," Tufts Medical Center specialist Alice Gottlieb said. "Therapy that targets the cytokines interleukin-12 and interleukin-23, two naturally occurring proteins believed to play a role in the development of this debilitating immune-mediated inflammatory disease, could improve patient care."


Like this story? Find us on Facebook for more insight, analysis and the latest in drug store news. Join the conversation.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
News

Ahold supervisory board member resigns

BY Alaric DeArment

ZAANDAM, Netherlands — Royal Ahold supervisory board member Tom de Swaan will resign at the end of this month, the company said Monday.

Netherlands-based Ahold, the parent company of Ahold USA and U.S. supermarket banners Stop & Shop, Giant Food of Landover, Md., and Giant Food Stores of Carlisle, Pa., as well as the online grocer Peapod, said de Swaan would resign effective Sept. 30.

De Swaan’s resignation is a result of his Sept. 11 appointment as chairman of Zurich Insurance Group. He was appointed to Ahold’s supervisory board in 2007 and served as chairman of the audit committee, a role that fellow board member Stephanie Shern will fill following his departure.


Like this story? Find us on Facebook for more insight, analysis and the latest in drug store news. Join the conversation.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?